Literature DB >> 8100588

Nitric oxide induces calcium-dependent [3H]dopamine release from striatal slices.

G Lonart1, K L Cassels, K M Johnson.   

Abstract

Hydroxylamine (0.01-30 mM), a nitric oxide (NO) generator, produced a concentration-dependent release of [3H]dopamine ([3H]DA) from rat striatal slices. Hemoglobin (10 microM), a NO scavenger, reduced basal [3H]DA release and blocked hydroxylamine (100 microM)-stimulated [3H]DA efflux. Tetrodotoxin (0.5 microM) had no significant effect. Sodium cyanide was used as a model compound to test the possibility that NO acted through blockade of mitochondrial electron transport. Calcium-free experimental buffer (1 mM EGTA) reduced basal release and the hydroxylamine response, while sodium cyanide-induced release did not change under these experimental conditions. Cadmium (200 microM), a non-selective inhibitor of voltage-dependent calcium channels, reduced the hydroxylamine response by 69%. Methylene blue (10 microM), an inhibitor of guanylate cyclase, produced a 3-fold increase in the basal release but had no significant effect on the hydroxylamine response. These data suggest that NO induces calcium-dependent [3H]DA release from the striatum via a mechanism which is independent of blockade of electron transport or activation of guanylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100588     DOI: 10.1002/jnr.490350210

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  15 in total

1.  Nitric oxide inhibits uptake of dopamine and N-methyl-4-phenylpyridinium (MPP+) but not release of MPP+ in rat C6 glioma cells expressing human dopamine transporter.

Authors:  Bo-Jin Cao; Maarten E A Reith
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo.

Authors:  G Wegener; V Volke; R Rosenberg
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

3.  Release of [3H]dopamine from striatal and cerebral cortical slices from rats with thioacetamide-induced hepatic encephalopathy: different responses to stimulation by potassium ions and agonists of ionotropic glutamate receptors.

Authors:  H D Borkowska; S S Oja; P Saransaari; J Albrecht
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

4.  Upregulation of (+)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin binding following intracerebroventricular administration of a nitric oxide generator.

Authors:  D R Wallace; R M Booze
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

Review 5.  Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice.

Authors:  T E Koeltzow; M Xu; D C Cooper; X T Hu; S Tonegawa; M E Wolf; F J White
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

Review 6.  Dopamine receptor-coupling defect in hypertension.

Authors:  Pedro A Jose; Gilbert M Eisner; Robin A Felder
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

7.  Carbon Monoxide, a Retrograde Messenger Generated in Postsynaptic Mushroom Body Neurons, Evokes Noncanonical Dopamine Release.

Authors:  Kohei Ueno; Johannes Morstein; Kyoko Ofusa; Shintaro Naganos; Ema Suzuki-Sawano; Saika Minegishi; Samir P Rezgui; Hiroaki Kitagishi; Brian W Michel; Christopher J Chang; Junjiro Horiuchi; Minoru Saitoe
Journal:  J Neurosci       Date:  2020-04-06       Impact factor: 6.167

8.  Nitric oxide alters GABAergic synaptic transmission in cultured hippocampal neurons.

Authors:  Santina Zanelli; Martha Naylor; Jaideep Kapur
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

9.  Cocaine kindling in mice. Responses to N-methyl-D,L-aspartate (NMDLA) and L-arginine.

Authors:  Y Itzhak
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

10.  Modulation of striatal dopamine release in cerebral ischemia by L-arginine.

Authors:  M Spatz; Y Yasuma; A Strasser; N Kawai; D Stanimirovic; R McCarron
Journal:  Neurochem Res       Date:  1995-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.